A
Price
$141.10
Change
+$1.50 (+1.07%)
Updated
Oct 16 closing price
Capitalization
40B
45 days until earnings call
Intraday Buy/Sell Signals
FLGT
Price
$22.80
Change
+$0.04 (+0.18%)
Updated
Oct 16 closing price
Capitalization
697.89M
19 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

A vs FLGT

Header iconA vs FLGT Comparison
Open Charts A vs FLGTBanner chart's image
Agilent Technologies
Price$141.10
Change+$1.50 (+1.07%)
Volume$2.18M
Capitalization40B
Fulgent Genetics
Price$22.80
Change+$0.04 (+0.18%)
Volume$165.59K
Capitalization697.89M
A vs FLGT Comparison Chart in %
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FLGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. FLGT commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and FLGT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (A: $141.10 vs. FLGT: $22.80)
Brand notoriety: A and FLGT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 127% vs. FLGT: 78%
Market capitalization -- A: $40B vs. FLGT: $697.89M
A [@Medical Specialties] is valued at $40B. FLGT’s [@Medical Specialties] market capitalization is $697.89M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $11.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 2 FA rating(s) are green whileFLGT’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 2 green, 3 red.
  • FLGT’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than FLGT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while FLGT’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 4 bearish.
  • FLGT’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, A is a better buy in the short-term than FLGT.

Price Growth

A (@Medical Specialties) experienced а +0.71% price change this week, while FLGT (@Medical Specialties) price change was +0.48% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.40%. For the same industry, the average monthly price growth was +2.99%, and the average quarterly price growth was +54.62%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

FLGT is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Medical Specialties (-1.40% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($40B) has a higher market cap than FLGT($698M). FLGT YTD gains are higher at: 23.443 vs. A (5.689). A has higher annual earnings (EBITDA): 1.8B vs. FLGT (-42.34M). A has more cash in the bank: 1.54B vs. FLGT (293M). FLGT has less debt than A: FLGT (7.39M) vs A (3.41B). A has higher revenues than FLGT: A (6.79B) vs FLGT (303M).
AFLGTA / FLGT
Capitalization40B698M5,731%
EBITDA1.8B-42.34M-4,244%
Gain YTD5.68923.44324%
P/E Ratio32.97N/A-
Revenue6.79B303M2,240%
Total Cash1.54B293M524%
Total Debt3.41B7.39M46,155%
FUNDAMENTALS RATINGS
A vs FLGT: Fundamental Ratings
A
FLGT
OUTLOOK RATING
1..100
7959
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
42
Fair valued
PROFIT vs RISK RATING
1..100
62100
SMR RATING
1..100
4594
PRICE GROWTH RATING
1..100
4446
P/E GROWTH RATING
1..100
337
SEASONALITY SCORE
1..100
7550

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (19) in the Biotechnology industry is in the same range as FLGT (42) in the Medical Or Nursing Services industry. This means that A’s stock grew similarly to FLGT’s over the last 12 months.

A's Profit vs Risk Rating (62) in the Biotechnology industry is somewhat better than the same rating for FLGT (100) in the Medical Or Nursing Services industry. This means that A’s stock grew somewhat faster than FLGT’s over the last 12 months.

A's SMR Rating (45) in the Biotechnology industry is somewhat better than the same rating for FLGT (94) in the Medical Or Nursing Services industry. This means that A’s stock grew somewhat faster than FLGT’s over the last 12 months.

A's Price Growth Rating (44) in the Biotechnology industry is in the same range as FLGT (46) in the Medical Or Nursing Services industry. This means that A’s stock grew similarly to FLGT’s over the last 12 months.

FLGT's P/E Growth Rating (7) in the Medical Or Nursing Services industry is in the same range as A (33) in the Biotechnology industry. This means that FLGT’s stock grew similarly to A’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AFLGT
RSI
ODDS (%)
Bearish Trend 4 days ago
66%
Bearish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
56%
Bullish Trend 4 days ago
68%
Momentum
ODDS (%)
Bullish Trend 4 days ago
62%
Bearish Trend 4 days ago
78%
MACD
ODDS (%)
Bullish Trend 4 days ago
61%
Bearish Trend 4 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
73%
Advances
ODDS (%)
Bullish Trend 15 days ago
61%
Bullish Trend 17 days ago
72%
Declines
ODDS (%)
Bearish Trend 8 days ago
60%
Bearish Trend 4 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
56%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
61%
Bullish Trend 4 days ago
70%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
FLGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
AAPR27.89-0.02
-0.09%
Innovator Eq Dfnd Prot ETF 2 YrToApl2026
REW5.78-0.01
-0.25%
ProShares UltraShort Technology
DFAU45.32-0.34
-0.74%
Dimensional US Core Equity Market ETF
DHY2.05-0.02
-0.97%
Credit Suisse High Yield
NIE25.34-0.26
-1.02%
Virtus Equity & Convertible Income Fund

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with TMO. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
+1.04%
TMO - A
80%
Closely correlated
+1.69%
WAT - A
79%
Closely correlated
+0.74%
RVTY - A
79%
Closely correlated
+2.04%
MTD - A
78%
Closely correlated
+4.26%
DHR - A
76%
Closely correlated
+2.34%
More

FLGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FLGT has been loosely correlated with BLFS. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FLGT jumps, then BLFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FLGT
1D Price
Change %
FLGT100%
+0.18%
BLFS - FLGT
40%
Loosely correlated
-3.55%
CERS - FLGT
40%
Loosely correlated
-0.63%
CSTL - FLGT
39%
Loosely correlated
+0.09%
BIO - FLGT
39%
Loosely correlated
+2.14%
A - FLGT
38%
Loosely correlated
+1.04%
More